Breaking News
ANNUAL REPORT 2023 | Unveiling TIF’s Impactful Achievements
REGULATORY APPROVAL | PiaSky Becomes the First Monthly Treatment for PNH in the EU
ACCESS TO INNOVATION | UK Greenlights Gene-Editing Therapy Casgevy for β-Thalassaemia Treatment
GLOBAL SURVEY | Understanding the Thalassaemia Community Health Literacy & Its Impact on Care
Understanding the Thalassaemia Community Health Literacy and Its Impact on Care
JUST LISTEN | Voices of PK Deficiency Episode on the Impact of New International Standards
NEW APPROVAL | FDA Endorses Piasky for Paroxysmal Nocturnal Hemoglobinuria
CAD | Enjaymo Not Cost-Effective at Current Price, According to US Study
SPOTLIGHT | TIF Wins Prestigious HemaSphere Award at EHA2024
NEW PUBLICATION | Nutrition in Thalassaemia: A Guide for Patients, Families, and Caregivers
English
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Home
/
EHA25
EHA25
News
June 25, 2020
25th EHA Annual Virtual Congress: TIF Brings you All the Latest Developments on Thalassaemia
Read More »
Back to top button
Close
Search for
